from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0587/yrbE2A

LFCtreatmentdescriptionclass of inhibitor

-0.204

Amikacinug/mL Amikacintranslation

-0.809

Cap5-10ug/mL Capreomycintranslation

-1.906

Rox10-50 ug/mL Roxithromycintranslation

-0.036

SM2-5 ug/mL Streptomycintranslation

-1.254

Tet5-10 ug/mL Tetracyclinetranslation

1.000

Rif0.2-5ug/mL Rifampicintranscription

0.486

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.500

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.303

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.393

CPZ10-50 ug/mL Chlorpromazinerespiration

0.004

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.111

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.940

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.134

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.193

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.396

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.813

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.371

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.565

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.352

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.905

KCN5-20 ug/mL Potassium cyaniderespiration

-1.015

NaN30.2-2 mM Sodium aziderespiration

0.098

Nigericin50 uM Nigericinrespiration

-1.021

TRC10-150 ug/mL Triclosanrespiration

-0.571

TRZ10-25 ug/mL Thioridazinerespiration

0.443

Valinomycin0.5-10 uM Valinomycinrespiration

-0.529

ZnSO42 mM ZnSO4respiration

-0.679

menadione6-10 ug/mL Menadionerespiration

0.012

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.312

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.327

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.010

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.904

NRP_1Non-replicating persistence stage 1dosRassociated

-0.014

Amp0.2mg/mL AmpicillincellWall

-0.343

Cephalexin20-100 ug/mL CephalexincellWall

-0.250

Cerulenin0.32-5 ug/mL CerulenincellWall

0.217

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.344

EMB10-20 ug/mL EthambutolcellWall

-0.497

Eta12-40 ug/mL EthionamidecellWall

-0.217

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.074

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.275

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.351

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.623

BZA0.12 mg/mL BenzamidearomaticAmides

0.573

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.689

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.388

H2O24 mM hydrogen peroxideDNAdamaging

0.304

Levo10 ug/mL LevofloxacinDNAdamaging

-0.398

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.273

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.246

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.057

UVUV-irradiationDNAdamaging

-0.076

ARP41-4 ug/mL Antitubercular compound ARP4?

0.157

Antimycin12.5-50 ug/mL Antimycin A?

0.429

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.567

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.746

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.873

PA8240.2-2 ug/mL PA-824?

0.227

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.396

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.132

Verapamil50 uM Verapamil?

-0.041

mercaptoethanol2 mM 2-Mercaptoethanol?

0.154

methoxatin10-20 ug/mL Methoxatin?